Scientific and Medical Equipment House Company (TADAWUL: 4014)
Saudi Arabia
· Delayed Price · Currency is SAR 51.70
-0.30 (-0.58%)
Nov 20, 2024, 3:13 PM AST
Scientific and Medical Equipment House Company Cash Flow Statement
Financials in millions SAR. Fiscal year is January - December.
Millions SAR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2017 |
| Net Income | 40.06 | 40.06 | 17.57 | 77.52 | 74.76 | 70.67 | Upgrade
|
| Depreciation & Amortization | 22.64 | 22.64 | 17.85 | 13.16 | 9.76 | 7.2 | Upgrade
|
| Loss (Gain) From Sale of Assets | -0.02 | -0.02 | -0.09 | -0.22 | -0.23 | 0.02 | Upgrade
|
| Provision & Write-off of Bad Debts | 21.51 | 21.51 | 39.43 | 4.47 | 0.43 | 2.75 | Upgrade
|
| Other Operating Activities | 425.38 | 34.15 | 33.21 | 16.29 | 19.66 | 21.65 | Upgrade
|
| Change in Accounts Receivable | -225.52 | -225.52 | 74.36 | -222.15 | 70.61 | 31.51 | Upgrade
|
| Change in Inventory | -10.37 | -10.37 | -4.58 | -12.15 | -58.15 | 4.84 | Upgrade
|
| Change in Accounts Payable | -18.76 | -18.76 | 8.34 | 6.88 | -0.79 | -7.35 | Upgrade
|
| Change in Unearned Revenue | 2.43 | 2.43 | -1.82 | -1.36 | 6.97 | -2.24 | Upgrade
|
| Change in Other Net Operating Assets | -6.75 | -6.75 | -37.52 | 45.52 | -5.7 | 33.78 | Upgrade
|
| Operating Cash Flow | 250.6 | -140.64 | 146.75 | -72.04 | 117.31 | 162.83 | Upgrade
|
| Operating Cash Flow Growth | - | - | - | - | -27.95% | - | Upgrade
|
| Capital Expenditures | -14.88 | -14.88 | -13.29 | -7.45 | -22.97 | -10.54 | Upgrade
|
| Sale of Property, Plant & Equipment | 1.08 | 1.08 | 0.17 | 0.24 | 0.24 | 0.07 | Upgrade
|
| Sale (Purchase) of Intangibles | 0.46 | 0.46 | -4.53 | - | - | - | Upgrade
|
| Investment in Securities | - | - | - | 11.67 | - | -9.99 | Upgrade
|
| Other Investing Activities | 12.65 | -1.59 | -3.64 | 0.2 | 0.2 | 0.19 | Upgrade
|
| Investing Cash Flow | -0.69 | -14.93 | -21.29 | 4.67 | -22.53 | -39.02 | Upgrade
|
| Short-Term Debt Issued | - | 1,071 | 1,007 | 798.04 | 509.71 | 430.88 | Upgrade
|
| Long-Term Debt Issued | - | - | 2.11 | 5.87 | 1.86 | - | Upgrade
|
| Total Debt Issued | 1,071 | 1,071 | 1,009 | 803.91 | 511.57 | 430.88 | Upgrade
|
| Short-Term Debt Repaid | - | -916.28 | -1,077 | -732.55 | -557.62 | -488.3 | Upgrade
|
| Long-Term Debt Repaid | - | -13.39 | -9.19 | -3.67 | -22.02 | -15.01 | Upgrade
|
| Total Debt Repaid | -929.66 | -929.66 | -1,086 | -736.21 | -579.63 | -503.31 | Upgrade
|
| Net Debt Issued (Repaid) | 141.01 | 141.01 | -77.2 | 67.7 | -68.06 | -72.42 | Upgrade
|
| Common Dividends Paid | - | - | -20 | -30 | - | -20 | Upgrade
|
| Other Financing Activities | -317.45 | -23.05 | -19.02 | -13.64 | -12.33 | -17.32 | Upgrade
|
| Financing Cash Flow | -176.45 | 117.95 | -116.23 | 24.06 | -80.39 | -109.74 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | -0 | - | - | - | - | 2.65 | Upgrade
|
| Net Cash Flow | 73.47 | -37.61 | 9.24 | -43.32 | 14.39 | 16.73 | Upgrade
|
| Free Cash Flow | 235.72 | -155.51 | 133.46 | -79.49 | 94.34 | 152.29 | Upgrade
|
| Free Cash Flow Growth | - | - | - | - | -38.05% | - | Upgrade
|
| Free Cash Flow Margin | 26.64% | -19.46% | 18.70% | -11.36% | 15.28% | 25.51% | Upgrade
|
| Free Cash Flow Per Share | 7.57 | -5.18 | 4.45 | -2.65 | 3.14 | 5.08 | Upgrade
|
| Cash Interest Paid | 23.05 | 23.05 | 19.02 | 12.68 | 12.33 | 19.28 | Upgrade
|
| Levered Free Cash Flow | - | -197.41 | 97.95 | -128.75 | 50.48 | 86.1 | Upgrade
|
| Unlevered Free Cash Flow | - | -181.61 | 110.23 | -120.66 | 58.33 | 98.27 | Upgrade
|
| Change in Net Working Capital | - | 231.16 | -87.58 | 177.86 | -17.27 | -60.12 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.